Literature DB >> 35678865

Isolation of Three Coliphages and the Evaluation of Their Phage Cocktail for Biocontrol of Shiga Toxin-Producing Escherichia coli O157 in Milk.

Lili Zhu1,2, Yanyan Hou1,2, Xi Huang1,2, Shuang Wang1,2, Rui Xie1,2, Jie Yang1,2, Qingjie Lv1,2, Lin Hua1,2, Wan Liang3, Zhong Peng4,5, Bin Wu6,7.   

Abstract

Shiga toxin-producing Escherichia coli (STEC) O157 is a well-known foodborne pathogen and a leading cause of many intestinal diseases. In this study, we explore the use of a phage cocktail to help control STEC O157 in broth and milk. We isolated three virulent phages from sanitary sewages using a STEC O157 as the indicator bacterium. Phenotypical characterizations revealed that these three phages belong to the Myoviridae family and were stable at different temperatures and pH. They displayed a short latent period between 10 and 20 min, and a burst size (32-65 per infected cell). No virulence factors and drug resistance genes were found in their genomes. Bacterial lysis assays showed that a phage cocktail comprising these three phages was more effective (at least 4.32 log reduction) against STEC O157 at 25 °C with multiplicity of infection (MOI) = 1000 in broth medium. At 4 °C, a 3.8 log reduction in the number of viable STEC O157 after 168-h treatment with phage cocktail at MOI = 1000 was observed in milk, compared to phage-free bacterial control group. Characterizations of phages suggest they could be developed into novel therapeutic agents to control STEC O157 in milk production.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh:

Year:  2022        PMID: 35678865     DOI: 10.1007/s00284-022-02908-3

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  43 in total

Review 1.  Enterohaemorrhagic and other Shiga toxin-producing Escherichia coli (STEC): Where are we now regarding diagnostics and control strategies?

Authors:  D G Newell; R M La Ragione
Journal:  Transbound Emerg Dis       Date:  2018-01-25       Impact factor: 5.005

Review 2.  The next generation of bacteriophage therapy.

Authors:  Timothy K Lu; Michael S Koeris
Journal:  Curr Opin Microbiol       Date:  2011-08-23       Impact factor: 7.934

3.  Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany.

Authors:  David A Rasko; Dale R Webster; Jason W Sahl; Ali Bashir; Nadia Boisen; Flemming Scheutz; Ellen E Paxinos; Robert Sebra; Chen-Shan Chin; Dimitris Iliopoulos; Aaron Klammer; Paul Peluso; Lawrence Lee; Andrey O Kislyuk; James Bullard; Andrew Kasarskis; Susanna Wang; John Eid; David Rank; Julia C Redman; Susan R Steyert; Jakob Frimodt-Møller; Carsten Struve; Andreas M Petersen; Karen A Krogfelt; James P Nataro; Eric E Schadt; Matthew K Waldor
Journal:  N Engl J Med       Date:  2011-07-27       Impact factor: 91.245

4.  Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15.

Authors:  Flavie Pouillot; Maryline Chomton; Hélène Blois; Celine Courroux; Julien Noelig; Philippe Bidet; Edouard Bingen; Stéphane Bonacorsi
Journal:  Antimicrob Agents Chemother       Date:  2012-04-09       Impact factor: 5.191

5.  Escherichia coli O157:H7 diarrhoea associated with well water and infected cattle on an Ontario farm.

Authors:  S G Jackson; R B Goodbrand; R P Johnson; V G Odorico; D Alves; K Rahn; J B Wilson; M K Welch; R Khakhria
Journal:  Epidemiol Infect       Date:  1998-02       Impact factor: 2.451

Review 6.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 7.  A century of the phage: past, present and future.

Authors:  George P C Salmond; Peter C Fineran
Journal:  Nat Rev Microbiol       Date:  2015-11-09       Impact factor: 60.633

8.  Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice.

Authors:  Fang Cao; Xitao Wang; Linhui Wang; Zhen Li; Jian Che; Lili Wang; Xiaoyu Li; Zhenhui Cao; Jiancheng Zhang; Liji Jin; Yongping Xu
Journal:  Biomed Res Int       Date:  2015-03-23       Impact factor: 3.411

Review 9.  Escherichia coli O157 Outbreaks in the United States, 2003-2012.

Authors:  Katherine E Heiman; Rajal K Mody; Shacara D Johnson; Patricia M Griffin; L Hannah Gould
Journal:  Emerg Infect Dis       Date:  2015-08       Impact factor: 6.883

Review 10.  Efficacy of φkm18p phage therapy in a murine model of extensively drug-resistant Acinetobacter baumannii infection.

Authors:  Jiun-Ling Wang; Chih-Feng Kuo; Che-Ming Yeh; Jung-Ren Chen; Ming-Fang Cheng; Chih-Hsin Hung
Journal:  Infect Drug Resist       Date:  2018-11-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.